EMMA
EIZAGUIRRE LETAMENDIA
Ikertzailea 2022-(e)ra arte
![Foto de EMMA](/img/nophoto.png)
![Foto de Hospital Universitario de Valme](/img/noimage_org.png)
Hospital Universitario de Valme
Sevilla, EspañaHospital Universitario de Valme -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2021
-
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Frontiers in Medicine, Vol. 8
-
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Gut, Vol. 70, Núm. 12, pp. 2359-2372